Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLKB1 | P03952 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 2/20 | 0.34 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.34 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.32 |
| ▸ | SLC8A1 | P32418 | 3/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.31 |
| ▸ | DHODH | Q02127 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1661096 | 0.98 | KLKB1 (0.37) | KLKB1POLBGSK3BNLRP3SCN9A | |
| SCHEMBL1660390 | 0.97 | KLKB1 (0.38) | KLKB1POLBGSK3BSCN9ATRPV1 | |
| SCHEMBL1659330 | 0.86 | POLB (0.40) | KLKB1POLBSCN9ACA1CA2 | |
| SCHEMBL1658941 | 0.86 | KLKB1 (0.40) | KLKB1POLBSCN9ATRPV1 | |
| SCHEMBL1659194 | 0.86 | KLKB1 (0.40) | KLKB1POLBSCN9ACA1CA2 | |
| SCHEMBL1661398 | 0.84 | KLKB1 (0.39) | KLKB1POLBSCN9ATRPV1CA1 | |
| SCHEMBL1659509 | 0.84 | KLKB1 (0.39) | KLKB1POLB | |
| SCHEMBL12604728 | 0.84 | PDE2A (0.37) | KLKB1NLRP3 | |
| SCHEMBL1986987 | 0.84 | PDE2A (0.37) | KLKB1NLRP3 | |
| SCHEMBL1660515 | 0.84 | SCN9A (0.40) | KLKB1POLBSCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2307394-A2 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | Amorepacific Corporation (KR) | 2011-04-13 | — | — | EP | disclosed |